KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Change in Cash (2016 - 2025)

Historic Change in Cash for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to $735.8 million.

  • Zimmer Biomet Holdings' Change in Cash rose 39415.72% to $735.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $723.6 million, marking a year-over-year increase of 16132.18%. This contributed to the annual value of $109.7 million for FY2024, which is 17356.61% up from last year.
  • As of Q3 2025, Zimmer Biomet Holdings' Change in Cash stood at $735.8 million, which was up 39415.72% from -$827.7 million recorded in Q2 2025.
  • Zimmer Biomet Holdings' Change in Cash's 5-year high stood at $859.1 million during Q1 2025, with a 5-year trough of -$827.7 million in Q2 2025.
  • Moreover, its 5-year median value for Change in Cash was -$27.6 million (2023), whereas its average is $25.8 million.
  • Within the past 5 years, the most significant YoY rise in Zimmer Biomet Holdings' Change in Cash was 388458.15% (2025), while the steepest drop was 315424.35% (2025).
  • Zimmer Biomet Holdings' Change in Cash (Quarter) stood at -$441.1 million in 2021, then skyrocketed by 61.53% to -$169.7 million in 2022, then skyrocketed by 172.83% to $123.6 million in 2023, then tumbled by 135.28% to -$43.6 million in 2024, then soared by 1787.61% to $735.8 million in 2025.
  • Its Change in Cash was $735.8 million in Q3 2025, compared to -$827.7 million in Q2 2025 and $859.1 million in Q1 2025.